The diabetes drug liraglutide (Victoza) secured an indication from the FDA to reduce the risk of major adverse cardiovascular (CV) events in adults with Type 2 diabetes and established cardiovascular disease, Novo Nordisk announced Aug. 25.

Patients with advanced renal dysfunction received no significant benefit from statin therapy following acute MI in a study of 861 individuals.

Researchers have found a distinctive reactionary pattern in the brain that could be used to identify individuals at greater risk for hypertension and cardiovascular disease (CVD) as a result of psychological stressors.

Federal statistics show college graduates live longer, healthier lives. People with higher educational attainment also have less lifetime risk of cardiovascular disease (CVD), according to a study in JAMA Internal Medicine.

When it comes to choosing whether to initiate statin treatment, similar clinical and economic consequences result if clinicians follow current guidelines or use coronary artery calcium (CAC) testing to guide that decision, according to new research.

Nearly nine in 10 patients with atherosclerotic cardiovascular disease (ASCVD) could improve their cholesterol levels with oral-only treatment, according to a new study.

Potentially modifiable midlife vascular risk factors could be associated with dementia later in life, according to a study.

In an effort to address the growing number of overweight and obese children in the U.S., the American Academy of Pediatrics, (AAP) is now recommending that pediatricians turn their attention to cardiometabolic risk factors associated with the condition.